Simpler Grants.gov #RFA-CA-26-011

Funding for Continuation of the Childhood Cancer Survivor Study (CCSS) by the National Cancer Institute

This opportunity from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), seeks to continue the Childhood Cancer Survivor Study (CCSS), a major collaborative research initiative. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - Purpose and Scope: - Funding supports the ongoing CCSS, a multi-institutional, multidisciplinary research resource - Involves health-related data from over 38,000 five-year survivors of pediatric and adolescent cancer, plus a sibling control group - Expands data collection to include survivors treated with modern therapies - Maintains a biorepository and data resource for cancer risk assessment and research - Products/Services Requested: - No specific OEMs, products, or equipment are requested - Primary service is research, data collection, and biorepository management - Unique/Notable Requirements: - Single-source cooperative agreement intended for the current CCSS award holder - Focus on longitudinal data and enabling both observational and intervention-based studies - Resource to be made available to the broader research community - No commercial OEMs or vendors are named, as this is a research funding opportunity, not a product or equipment procurement.

Description

The National Cancer Institute (NCI) intends to support the continuation of the Childhood Cancer Survivor Study (CCSS), which investigates long-term morbidity and mortality associated with cancer treatments. The CCSS is a multi-institutional, multidisciplinary collaborative research resource with health-related data from over 38,000 five-year survivors of pediatric and adolescent cancer patients and a sibling control cohort. This funding opportunity seeks to obtain additional age-related longitudinal information from the current cohort and include pediatric cancer survivors receiving modern therapies. The goal is to serve as a data resource and biorepository for researchers to conduct cancer risk assessments and research studies aimed at improving cancer treatments.

View original listing